Article Details

COVID-19 in 2025: Addressing disease burden, access inequities and economic impact

Retrieved on: 2025-02-22 23:04:23

Tags for this article:

Click the tags to see associated articles and topics

COVID-19 in 2025: Addressing disease burden, access inequities and economic impact. View article details on hiswai:

Summary

The article outlines the ongoing challenges and advancements in managing COVID-19, focusing on new treatments, healthcare inequities, and economic impacts. Key antivirals like Remdesivir and Nirmatrelvir/Ritonavir show promise in reducing severe outcomes. Overcoming access barriers to these treatments is crucial for equitable healthcare.

Article found on: www.managedhealthcareexecutive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up